XU Hua-xi
- Co-authors
- Siamak Sandoghchian ShotorbaniZhaoliang SuNavid ShomaliSeidu A. RichardMorteza AkbariJavad MahmoudiYing XuZhihui Zhang
- Topics
- MicroRNA in disease regulation (3 papers)Neuroinflammation and Neurodegeneration Mechanisms (3 papers)Advanced Glycation End Products research (3 papers)
In The Last Decade
XU Hua-xi
19 papers receiving 342 citations
Peers
Comparison fields: 5 of 73
- Molecular Biology 172
- Immunology 91
- Cancer Research 83
- Oncology 53
- Epidemiology 37
Countries citing papers authored by XU Hua-xi
This map shows the geographic impact of XU Hua-xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by XU Hua-xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites XU Hua-xi more than expected).
Fields of papers citing papers by XU Hua-xi
This network shows the impact of papers produced by XU Hua-xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by XU Hua-xi. The network helps show where XU Hua-xi may publish in the future.
Co-authorship network of co-authors of XU Hua-xi
This figure shows the co-authorship network connecting the top 25 collaborators of XU Hua-xi. A scholar is included among the top collaborators of XU Hua-xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with XU Hua-xi. XU Hua-xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 42 | |
| 3 | 16 | |
| 4 | 35 | |
| 5 | 32 | |
| 6 | 14 | |
| 7 | 5 | |
| 8 | 11 | |
| 9 | 10 | |
| 10 | 46 | |
| 11 | 3 | |
| 12 | 35 | |
| 13 | 28 | |
| 14 | 5 | |
| 15 | 45 | |
| 16 | [Release of HMGB1 by LPS-treated cardiac fibroblasts and its contribution to the production of collagen type I and III]. | 4 |
| 17 | 9 | |
| 18 | IL-4 can inhibit IL-17 production in collagen induced arthritis. | 8 |
| 19 | Drug resistance and transposon and insertion sequence of multi-drug resistant Acinetobacter baumannii. | 1 |
About XU Hua-xi
XU Hua-xi is a scholar working on Clinical Biochemistry, Neurology and Immunology, having authored 19 papers that have together received 353 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Advanced Glycation End Products research (3 papers). The work is most often cited by research in Drug Discovery (1 citation), Cancer Research (83 citations) and Clinical Biochemistry (35 citations). XU Hua-xi has collaborated with scholars based in China, Iran and Hong Kong. Frequent co-authors include Siamak Sandoghchian Shotorbani, Zhaoliang Su, Navid Shomali, Seidu A. Richard, Morteza Akbari, Javad Mahmoudi, Ying Xu, Zhihui Zhang, Ata Mahmoodpoor and Yongzhong Hou. Their work appears in journals such as Oncogene, International Journal of Molecular Sciences and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.